AT332125T - Emulsions for in situ drug delivery systems - Google Patents

Emulsions for in situ drug delivery systems

Info

Publication number
AT332125T
AT332125T AT99107131T AT99107131T AT332125T AT 332125 T AT332125 T AT 332125T AT 99107131 T AT99107131 T AT 99107131T AT 99107131 T AT99107131 T AT 99107131T AT 332125 T AT332125 T AT 332125T
Authority
AT
Austria
Prior art keywords
emulsions
drug delivery
delivery systems
situ drug
situ
Prior art date
Application number
AT99107131T
Other languages
German (de)
Inventor
Richard L Dunn
Original Assignee
Qlt Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/060,047 priority Critical patent/US7128927B1/en
Application filed by Qlt Usa Inc filed Critical Qlt Usa Inc
Publication of AT332125T publication Critical patent/AT332125T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y02A50/46Medical treatment of waterborne diseases characterized by the agent
    • Y02A50/462The waterborne disease being caused by a virus
    • Y02A50/465The waterborne disease being caused by a virus the virus being the poliovirus, i.e. Poliomyelitis or Polio
AT99107131T 1998-04-14 1999-04-13 Emulsions for in situ drug delivery systems AT332125T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/060,047 US7128927B1 (en) 1998-04-14 1998-04-14 Emulsions for in-situ delivery systems

Publications (1)

Publication Number Publication Date
AT332125T true AT332125T (en) 2006-07-15

Family

ID=22026994

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99107131T AT332125T (en) 1998-04-14 1999-04-13 Emulsions for in situ drug delivery systems

Country Status (8)

Country Link
US (1) US7128927B1 (en)
EP (1) EP0950403B1 (en)
JP (1) JPH11343228A (en)
AT (1) AT332125T (en)
DE (1) DE69932201T2 (en)
DK (1) DK0950403T3 (en)
ES (1) ES2272024T3 (en)
PT (1) PT950403E (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6565874B1 (en) * 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US6296607B1 (en) * 2000-10-20 2001-10-02 Praxis, Llc. In situ bulking device
KR100446101B1 (en) * 2000-12-07 2004-08-30 주식회사 삼양사 Sustained delivery composition for poorly water soluble drugs
OA12731A (en) 2001-11-30 2006-06-28 Pfizer Controlled release polymeric compositions of bone growth promoting compounds.
EP1344538A1 (en) 2002-03-14 2003-09-17 Degradable Solutions AG Porous biodegradable implant material and method for its fabrication
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
WO2004039354A1 (en) * 2002-11-01 2004-05-13 Mirador Dna Design Inc. Solvent for chromogenic substrate solution
DE10312346A1 (en) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Controlled release system
US8163030B2 (en) 2004-05-06 2012-04-24 Degradable Solutions Ag Biocompatible bone implant compositions and methods for repairing a bone defect
TWI369218B (en) * 2004-12-14 2012-08-01 Novartis Ag In situ forming implant for animals
WO2007082726A2 (en) * 2006-01-17 2007-07-26 Medigene Ag Flowable leuprolide-containing composition for treating inflammation-mediated neurodegenerative diseases
AR070033A1 (en) * 2007-11-06 2010-03-10 Panacea Biotec Ltd Injectable compositions, processes and uses
EP2219620B1 (en) * 2007-11-13 2017-07-19 Surmodics, Inc. Viscous terpolymers as drug delivery platform
US20090181068A1 (en) 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
US9415197B2 (en) * 2008-12-23 2016-08-16 Surmodics, Inc. Implantable suction cup composites and implants comprising same
US20100158978A1 (en) * 2008-12-23 2010-06-24 Peter Markland Bioactive spray coating compositions and methods of making and uses thereof
US20100168807A1 (en) * 2008-12-23 2010-07-01 Burton Kevin W Bioactive terpolymer compositions and methods of making and using same
US9480643B2 (en) * 2008-12-23 2016-11-01 Surmodics Pharmaceuticals, Inc. Implantable composites and implants comprising same
US8974808B2 (en) * 2008-12-23 2015-03-10 Surmodics, Inc. Elastic implantable composites and implants comprising same
US8951546B2 (en) * 2008-12-23 2015-02-10 Surmodics Pharmaceuticals, Inc. Flexible implantable composites and implants comprising same
WO2012030822A1 (en) 2010-08-30 2012-03-08 Surmodics Pharmaceuticals, Inc. Process for reducing moisture in a biodegradable implant device

Family Cites Families (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2155658A (en) 1936-01-08 1939-04-25 Chemische Forschungs Gmbh Surgical and medical preparations
BE565269A (en) 1957-03-27
US3328246A (en) 1957-08-20 1967-06-27 Bicrex Lab Ltd Dental compositions and methods of making same
US3218283A (en) 1962-07-26 1965-11-16 Monsanto Co Novel solutions of poly-(acrylic anhydride) and poly-(methacrylic anhydride) polymers
US3219527A (en) 1963-06-17 1965-11-23 Loyola University Peridontal pack or dressing composition
US3463158A (en) 1963-10-31 1969-08-26 American Cyanamid Co Polyglycolic acid prosthetic devices
US3520949A (en) 1966-07-26 1970-07-21 Nat Patent Dev Corp Hydrophilic polymers,articles and methods of making same
US3887699A (en) 1969-03-24 1975-06-03 Seymour Yolles Biodegradable polymeric article for dispensing drugs
US3767784A (en) 1970-12-01 1973-10-23 S Gluck Composition for the protection and treatment of injured body tissue and method of utilizing the same
US3760034A (en) 1971-01-26 1973-09-18 Union Carbide Corp Graft copolymers of lactone polyesters
US3755558A (en) 1971-02-23 1973-08-28 Du Pont Polylactide drug mixtures for topical application atelet aggregation
US3696811A (en) 1971-06-17 1972-10-10 Squibb & Sons Inc Periodontal bandage and backing therefor
US3975350A (en) 1972-08-02 1976-08-17 Princeton Polymer Laboratories, Incorporated Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles
US4450150A (en) 1973-05-17 1984-05-22 Arthur D. Little, Inc. Biodegradable, implantable drug delivery depots, and method for preparing and using the same
US3919773A (en) 1973-12-20 1975-11-18 Sybron Corp Direct moldable implant material
US3939111A (en) 1974-07-01 1976-02-17 The B. F. Goodrich Company Stable polyurethane solutions
US3935308A (en) 1974-08-08 1976-01-27 The United States Of America As Represented By The Secretary Of The Navy Wound covering and method of application
US3931678A (en) 1974-09-24 1976-01-13 Loctite (Ireland) Limited Dental filling method and composition formed thereby
US3949073A (en) 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
CH625702A5 (en) 1977-01-18 1981-10-15 Delalande Sa
US4148871A (en) 1977-10-11 1979-04-10 Pitt Colin G Sustained subdermal delivery ofdrugs using poly(ε-caprolactone) and its copolymers
US4265247A (en) 1979-11-07 1981-05-05 Research Corporation Malic acid polymers
US4294753A (en) 1980-08-04 1981-10-13 The Regents Of The University Of California Bone morphogenetic protein process
US4761471A (en) 1980-08-04 1988-08-02 The Regents Of The University Of California Bone morphogenetic protein composition
US4789732A (en) 1980-08-04 1988-12-06 Regents Of The University Of California Bone morphogenetic protein composition
US4408023A (en) 1980-11-12 1983-10-04 Tyndale Plains-Hunter, Ltd. Polyurethane diacrylate compositions useful for contact lenses and the like
DE3045135A1 (en) 1980-11-29 1982-06-09 Sandoz Ag Pharmaceutical compositions containing biodegradable polymeric
JPS62707B2 (en) 1980-12-29 1987-01-09 Teijin Ltd
US4793336A (en) 1981-03-25 1988-12-27 Wang Paul Y Wound coverings and processes for their preparation
US4455256A (en) 1981-05-05 1984-06-19 The Regents Of The University Of California Bone morphogenetic protein
US4619989A (en) 1981-05-05 1986-10-28 The Regents Of The University Of Cal. Bone morphogenetic protein composition
US4795804A (en) 1983-08-16 1989-01-03 The Regents Of The University Of California Bone morphogenetic agents
US4447562A (en) 1981-07-15 1984-05-08 Ivani Edward J Amino-polysaccharides and copolymers thereof for contact lenses and ophthalmic compositions
US4582640A (en) 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
US4570629A (en) 1982-03-17 1986-02-18 University Of Illinois Foundation Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressing comprising same
EP0092329B1 (en) 1982-04-07 1988-07-27 Bernard Paul Philippe Feinmann Improved material and method for dentistry
DE3378250D1 (en) 1982-04-22 1988-11-24 Ici Plc Continuous release formulations
CA1211266A (en) 1982-11-12 1986-09-16 Alfred E. Lauchenauer Shaped semi-solid articles
US4443430A (en) 1982-11-16 1984-04-17 Ethicon, Inc. Synthetic absorbable hemostatic agent
US4439420A (en) 1982-11-16 1984-03-27 Ethicon, Inc. Absorbable hemostatic composition
US4721613A (en) 1982-12-13 1988-01-26 Alza Corporation Delivery system comprising means for shielding a multiplicity of reservoirs in selected environment of use
US4622219A (en) 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
US4904478A (en) 1983-08-11 1990-02-27 Mission Pharmacal Company Slow-release sodium fluoride tablet and method for treatment of osteoporosis
US4631188A (en) 1983-08-31 1986-12-23 S.K.Y. Polymers, Ltd. (Kingston Technologies) Injectable physiologically-acceptable polymeric composition
US4685883A (en) 1983-09-12 1987-08-11 Jernberg Gary R Local delivery of chemotherapeutic agents for the treatment of periodontal disease
US4932973A (en) 1983-09-30 1990-06-12 El Gendler Cartilage and bone induction by artificially perforated organic bone matrix
JPH0157087B2 (en) * 1983-11-04 1989-12-04 Takeda Chemical Industries Ltd
US4818542A (en) 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
US4526909A (en) 1984-01-09 1985-07-02 Regents Of The University Of California Polymethylmethacrylate delivery system for bone morphogenetic protein
US4563489A (en) 1984-02-10 1986-01-07 University Of California Biodegradable organic polymer delivery system for bone morphogenetic protein
US4596574A (en) 1984-05-14 1986-06-24 The Regents Of The University Of California Biodegradable porous ceramic delivery system for bone morphogenetic protein
US4663077A (en) 1984-06-11 1987-05-05 Morton Thiokol Inc. Microbiocidal compositions comprising an aryl alkanol and a microbiocidal compound dissolved therein
GB8416234D0 (en) 1984-06-26 1984-08-01 Ici Plc Biodegradable amphipathic copolymers
AT128715T (en) 1984-07-16 1995-10-15 Celtrix Pharma Polypeptides inducing factors in bone and cartilage.
US4729999A (en) 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency
US4687768A (en) 1984-12-21 1987-08-18 The Procter & Gamble Company Certain hexahydroindan-2,2-diphosphonic acids useful in treating diseases associated with abnormal calcium and phosphate metabolism
US5049386A (en) 1985-01-07 1991-09-17 Syntex (U.S.A.) Inc. N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4595713A (en) 1985-01-22 1986-06-17 Hexcel Corporation Medical putty for tissue augmentation
DE3678308D1 (en) * 1985-02-07 1991-05-02 Takeda Chemical Industries Ltd A process for the preparation of microcapsules.
JPH0720859B2 (en) * 1985-02-07 1995-03-08 武田薬品工業株式会社 Microcapsule production method
US4650665A (en) 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4568536A (en) 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
EP0200508B1 (en) 1985-04-27 1991-10-02 Nitto Denko Corporation Adhesive oral bandages and oral pharmaceutical preparations
US4857456A (en) 1985-04-30 1989-08-15 The Regents Of The University Of California Assay of Bone morphogenetic protein (BMP) and anti-BMP antibody for the diagnosis of bone disorders
US4767627A (en) 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
DE3519361A1 (en) 1985-05-30 1986-12-04 Boehringer Ingelheim Int (Gamma) IFN as an active ingredient for inhibiting (preventing) of degradation processes in the bones
US4702917A (en) 1985-11-18 1987-10-27 Research Triangle Institute Porous bioabsorbable polyesters
US4767861A (en) 1986-01-28 1988-08-30 Vipont Laboratories Recovery of benzo-c-phenanthridine alkaloids
US4774227A (en) 1986-02-14 1988-09-27 Collagen Corporation Collagen compositions for bone repair containing autogeneic marrow
JPH0584282B2 (en) 1986-03-25 1993-12-01 Rohto Pharma
US4919939A (en) 1986-04-29 1990-04-24 Pharmetrix Corporation Periodontal disease treatment system
US4780320A (en) 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
US4962091A (en) 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US4946870A (en) 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
DE3623397A1 (en) 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh New diphosphonic acid derivatives, processes for their preparation and these compounds containing drug
US4857602A (en) 1986-09-05 1989-08-15 American Cyanamid Company Bioabsorbable surgical suture coating
FI81010C (en) 1986-09-05 1990-09-10 Biocon Oy Stoedstruktur Foer bentransplantat.
US5227157A (en) 1986-10-14 1993-07-13 Board Of Regents, The University Of Texas System Delivery of therapeutic agents
US4905680A (en) 1986-10-27 1990-03-06 Johnson & Johnson Orthopaedics, Inc. Absorbable bone plate
US4902296A (en) 1986-10-29 1990-02-20 The University Of Virginia Alumni Patents Foundation Use of demineralized bone matrix in the repair of segmental defects
US4800219A (en) 1986-12-22 1989-01-24 E. I. Du Pont De Nemours And Company Polylactide compositions
US4981696A (en) 1986-12-22 1991-01-01 E. I. Du Pont De Nemours And Company Polylactide compositions
US4861627A (en) 1987-05-01 1989-08-29 Massachusetts Institute Of Technology Preparation of multiwall polymeric microcapsules
US4983689A (en) 1987-05-07 1991-01-08 Yu Simon H Process for making macromolecular monomers of polylactones with terminal acryloyl unsaturation and block copolymers thereof
US5013553A (en) 1987-06-30 1991-05-07 Vipont Pharmaceutical, Inc. Drug delivery devices
US4912141A (en) 1987-07-28 1990-03-27 Kronman Joseph H Fibrous and cartilaginous tissue replacement
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US4911931A (en) 1987-08-03 1990-03-27 Baylink David J Pharmaceutical combination for treatment of bone-wasting diseases
US4804691A (en) 1987-08-28 1989-02-14 Richards Medical Company Method for making a biodegradable adhesive for soft living tissue
GB2209937B (en) 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
US4920203A (en) 1987-12-17 1990-04-24 Allied-Signal Inc. Medical devices fabricated from homopolymers and copolymers having recurring carbonate units
US4961707A (en) 1987-12-22 1990-10-09 University Of Florida Guided periodontal tissue regeneration
US4916241A (en) 1988-06-06 1990-04-10 American Home Products Corporation Inhibition of bone loss by 4-substituted-5-hydroxy-2(5H)-furanones
US5250584A (en) 1988-08-31 1993-10-05 G-C Dental Industrial Corp. Periodontium-regenerative materials
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5019400A (en) 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
US5007940A (en) 1989-06-09 1991-04-16 American Medical Systems, Inc. Injectable polymeric bodies
US5077049A (en) 1989-07-24 1991-12-31 Vipont Pharmaceutical, Inc. Biodegradable system for regenerating the periodontium
US5188837A (en) 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
JP2653255B2 (en) * 1990-02-13 1997-09-17 武田薬品工業株式会社 Long-term sustained-release microcapsules
US5238714A (en) 1990-10-02 1993-08-24 Board Of Regents, The University Of Texas System Efficient microcapsule preparation and method of use
US5149543A (en) 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
US5176907A (en) 1991-08-13 1993-01-05 The Johns Hopkins University School Of Medicine Biocompatible and biodegradable poly (phosphoester-urethanes)
FR2710531B1 (en) * 1993-09-28 1995-12-22 Flamel Tech Sa Aerosol composition capable of forming a hydrogel, the hydrogel thus obtained and their application as a bandage.
KR100374098B1 (en) * 1994-04-08 2003-06-09 아트릭스 라보라토리스, 인코포레이션 Liquid delivery composition suitable for the controlled release implant formed
WO1996021427A1 (en) * 1995-01-09 1996-07-18 Atrix Laboratories, Inc. Liquid polymer delivery system
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
DE19545257A1 (en) * 1995-11-24 1997-06-19 Schering Ag A process for the production of morphologically uniform microcapsules and produced by this process microcapsules
ES2256898T3 (en) * 1996-12-20 2006-07-16 Alza Corporation Gel composition and procedures.

Also Published As

Publication number Publication date
DE69932201D1 (en) 2006-08-17
EP0950403A2 (en) 1999-10-20
US7128927B1 (en) 2006-10-31
DK0950403T3 (en) 2006-11-06
DE69932201T2 (en) 2007-06-14
ES2272024T3 (en) 2007-04-16
JPH11343228A (en) 1999-12-14
EP0950403A3 (en) 2000-04-12
PT950403E (en) 2006-11-30
EP0950403B1 (en) 2006-07-05

Similar Documents

Publication Publication Date Title
DE69816980D1 (en) Implantable diffusion delivery system
DE69633666D1 (en) Location determination system for cellular
DE69725574D1 (en) Recovery device for injectable drug
BR0011562B1 (en) apparatus and method for treating a fluid biolàgico.
DE59809311D1 (en) Catheter system for transdermal passage devices
DE69940893D1 (en) Collection assembly for drug
DK1115381T3 (en) Delivery system for proteinaceous drugs, using membranmimetika
PT1188526E (en) System razor
BR9901669B1 (en) automated consolidation station.
BR9706897B1 (en) pharmaceutical dosage form.
AT411004T (en) Drug delivery system for photosensitizers
DE69816172D1 (en) Liquid-controlled stent delivery system
PT1100781E (en) High affinity ligands for the nociceptin-ORL-1 receptor
IT1298924B1 (en) Management system for business operations
RU2000131695A (en) drug delivery system
DE69836334D1 (en) Drug delivery device
BR9904281B1 (en) medication dispensing assembly
AT431992T (en) Management system for attendance call center
AT272576T (en) Filtering means for liquids
DE69805997D1 (en) Applicator for semisolid drug
DE69813031D1 (en) Petroleum processing method in situ
BR0008458B1 (en) Sealing system for the filter.
DE69842146D1 (en) Dispensing assembly for Fibringemisch
BR9801027B1 (en) distribuiÇço system drugs.
AT209946T (en) Turf system for stadium

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0950403

Country of ref document: EP